CymaBay Therapeutics, Inc.
NASDAQ:CBAY
32.48 (USD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -105.37 | -106.001 | -89.998 | -50.986 | -102.808 | -72.548 | -27.557 | -26.671 | -15.529 | -31.917 | -10.073 | -11.255 |
| Depreciation & Amortization
| 0.681 | 0.71 | 0.688 | 0.632 | 0.572 | 0.105 | 0.035 | 0.029 | 0.022 | 0.018 | 0.055 | 0.119 |
| Deferred Income Tax
| -2.732 | 0 | 0.637 | 0 | -3.147 | 1.75 | 5.574 | 0.05 | -10.61 | 7.691 | -0.09 | 0 |
| Stock Based Compensation
| 15.23 | 9.517 | 9.996 | 7.324 | 10.468 | 7.013 | 4.92 | 2.473 | 2.487 | 1.292 | 0.892 | 0.081 |
| Change In Working Capital
| 5.632 | -2.339 | 6.351 | -1.591 | -3.906 | 8.859 | -3.041 | 0.29 | 0.078 | 1.604 | 0.701 | -0.298 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 5 | -5 | 0 | 0.211 | -0.101 | -0.002 | 0.016 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 1.427 | 0 | 0.938 | 0.304 | 0.699 | 0.719 |
| Accounts Payables
| 2.732 | -1.444 | 2.309 | -2.272 | 0.53 | 0.662 | 0.412 | -0.109 | -1.077 | 1.388 | 0.04 | -0.951 |
| Other Working Capital
| 2.9 | -0.895 | 4.042 | 0.681 | -4.436 | 8.197 | 0.12 | 0.399 | 0.006 | 0.013 | -0.036 | -0.082 |
| Other Non Cash Items
| 14.028 | 14.033 | 2.895 | -0.104 | 0.91 | -0.115 | 0.437 | 0.476 | 0.228 | 0.198 | 0.057 | 0.06 |
| Operating Cash Flow
| -72.531 | -84.08 | -69.431 | -44.725 | -97.911 | -54.936 | -19.632 | -23.353 | -23.324 | -21.114 | -8.458 | -11.293 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.445 | -0.148 | -0.087 | -0.021 | -0.315 | -0.529 | -0.027 | -0.042 | 0 | -0.103 | 0 | 0 |
| Acquisitions Net
| -7.864 | -0.874 | 0.637 | -0.104 | -2.237 | -1.945 | -0.199 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -305.674 | -174.977 | -78.084 | -176.3 | -290.893 | -276.382 | -98.385 | -22.906 | -42.788 | -27.334 | -6.933 | -2.881 |
| Sales Maturities Of Investments
| 219.55 | 129.14 | 126.76 | 224.278 | 256.861 | 222.8 | 30.884 | 50.076 | 31.705 | 10.499 | 0.044 | 13.891 |
| Other Investing Activites
| 7.864 | 0.874 | -0.637 | 0.104 | 2.237 | 1.945 | 0.199 | 27.17 | -11.083 | -16.835 | 0.658 | 11.01 |
| Investing Cash Flow
| -86.569 | -45.985 | 48.589 | 47.957 | -34.347 | -54.111 | -67.528 | 27.128 | -11.083 | -16.938 | -6.231 | 11.01 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | -47.737 | 0 | 0 | -6.527 | -3.137 | -0.986 | -4.756 | -0.244 | 0 | -0.012 |
| Common Stock Issued
| 345.772 | 0 | 70.499 | 0.092 | 107.746 | 135.52 | 100.436 | 0 | 25.375 | 25.43 | 26.514 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.003 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 335.14 | 24.55 | 95.693 | 0.092 | 0.386 | 5.995 | 2.42 | -0.986 | 9.908 | 0.051 | 4.853 | -0.012 |
| Financing Cash Flow
| 345.772 | 24.55 | 118.455 | 0.092 | 108.132 | 134.988 | 99.719 | -0.986 | 30.527 | 25.237 | 31.364 | -0.012 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.428 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 186.244 | -105.515 | 97.613 | 3.324 | -24.126 | 25.941 | 12.559 | 2.789 | -3.88 | -12.815 | 16.675 | -0.295 |
| Cash At End Of Period
| 206.535 | 20.291 | 125.806 | 28.193 | 24.869 | 48.995 | 23.054 | 10.495 | 7.706 | 11.586 | 24.401 | 7.726 |